LifeArc
Non-profit
LifeArc® is a medical research charity making life science life changing, transforming promising life science ideas into medical breakthroughs that change patients’ lives.
We are self-funding and specialise in early-stage translation – advancing lab-based scientific discoveries to a point at which they can be developed into the next generation of diagnostics, treatments and cures.
We have been doing this for more than 25 years and our work has resulted in a diagnostic for antibiotic resistance and four licensed medicines. This includes Keytruda®(cancer), Actemra® (rheumatoid arthritis), Tysabri® (multiple sclerosis) and Entyvio® (Crohn’s disease) and a test for antimicrobial resistance. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United Kingdom |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesCelebrating 2 years of the network driving innovation for people with CF
This month marks 2 years of the Translational Innovation Hub Network for Cystic Fibrosis Lung Health and Infection, the CF Lung Health Network for short. The Network is made up of 4 Innovation Hubs based in Cambridge, Liverpool, London and Manchester.
What makes cystic fibrosis research such a rewarding career?
Over the last decade, advances in treatments have transformed outcomes for many people living with cystic fibrosis (CF). But significant challenges remain, including chronic lung infections and exacerbations. The Translational Innovation Hub Network for Lung Health and Infection in Cystic Fibrosis, known as the CF Lung Health Network for short, brings together researchers, clinicians and people with lived experience from across the UK to tackle some of these challenges.
7 lessons from our childhood cancer workshops
Over the past two years, we’ve held 12 workshops for 12 childhood cancers with high unmet therapeutic needs – bringing together the best expertise with the best evidence to map a clear path towards improved treatments. In areas where data, expertise and resources are limited and can be distributed across different groups and geographies, convening is no easy task. From scope and design to participant selection, due diligence and follow-up, we’re sharing what we did and what we learned.
Introducing Raremap: a new way to navigate the rare disease landscape - LifeArc
LifeArc has collaborated with Rare Disease Research UK to launch Raremap, the UK’s first directory of rare disease organisations. There’s a vibrant and diverse ecosystem of organisations working to improve outcomes for people affected by rare conditions. Patient groups, charities, researchers, funders, healthcare organisations, government bodies and biotechnology companies all play important roles in advancing tests, treatments and care.
LifeArc Translational Science Summit 2026: Charting new paths for rare disease - LifeArc
On 12 May, the LifeArc Translational Science Summit (LATSS) convened 700 stakeholders from research, healthcare, industry, investment, policy and the patient community to focus on one shared challenge: how to turn scientific discovery into real‑world benefit for patients, faster. Across a full day of talks and discussion, a clear message emerged: while scientific progress continues at pace, delivering real-world impact requires new approaches to translation, collaboration and system design.
From curiosity to career: LifeArc placement students share their stories for British Science Week Original
Curiosity is where every scientific journey begins. To celebrate British Science Week and this year’s theme of curiosity, we’re passing the mic to some of the most inquisitive minds at LifeArc – our industrial placement students and degree apprentices. Working across disciplines, they’ve been discovering what it really means to turn curiosity into impact.
International Women’s Day 2026: Stories of support, confidence and paying it forward - LifeArc Original
International Women’s Day 2026 is framed by a clear call from the United Nations: Rights. Justice. Action. For ALL Women and Girls. It’s a reminder that while progress has been made, structural barriers – in law, culture and opportunity – still shape women’s experiences at work and beyond. Alongside this, the global ‘Give to Gain’ campaign emphasises the power of generosity and support, recognising that when we invest in women, we all benefit.
The future of brain health: Early detection, equity and systematic change - LifeArc Original
The brain is the foundation of how we live, work, and connect and as societies age, the burden of brain-health conditions is rapidly rising. By 2050, more than 2.1 billion people will be over the age of 60, and the number of people living with dementia is projected to triple to 150 million. We are entering a pivotal era in which brain health must become a global priority, but progress will depend on more than scientific discovery alone.
Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin
A major international research project is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer’s disease. The trial is looking at three proteins in the blood that are associated with Alzheimer’s and comparing this with the current gold standard approach to diagnosing the disease that uses expensive brain scans and invasive procedures which can be inaccessible for many.
We must confront this silent pandemic as a global collective
Antimicrobial resistance (AMR) is often called the silent pandemic but for those of us working in this space, we are all too aware that millions of lives are already being lost and that the numbers continue to rise. This week, the WHO released a stark insight into the scale of the crisis: in 2023, 1 in 6 laboratory-confirmed bacterial infections globally were resistant to antibiotics. For infections like UTIs, it was 1 in 3.